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INVITED COMMENTARY
Minimally invasive analgesia after cardiac surgery
Tiziano Cassina
European Journal of Anaesthesiology 2017, 34:54–55
During the pioneer phase of cardiac surgery, postopera-
tive pain was considered a minor clinical adverse effect.
At that time, the attention of the cardiac anaesthetist was
focused on the risk of postoperative cardiovascular failure
rather than on the patient’s comfort. The main fear was
postoperative myocardial depression induced by ischae-
mia during aortic clamping and cardioplegic cardiac arrest
during extracorporeal circulation. The paradigm pro-
posed was a protective, haemodynamically stable, high-
dose opioid narcosis. General anaesthesia was based on
large amounts of intravenous opioids to induce profound
analgesia in response to surgical stimulation. The aim was
to avoid hypertension and tachycardia when the surgeon
performed sternotomy. The bradycardia produced by the
opioids was viewed as a suitable effect in patients with
ischaemic heart disease, as beta blockers were not rou-
tinely utilised in the perioperative period. However, due
to its slow metabolism, large amounts or repeated small
doses of fentanyl resulted in higher and longer lasting
plasma concentrations.1 As a result, the patient took
advantage of a progressive smooth awakening after
surgery, supported by the ventilator and mechanical
ventilation in the ICU. Over time, the number of cardiac
surgery patients rapidly increased thereby creating extra
pressure on the availability of beds in ICU. As a con-
sequence, the approach had to be changed and a different
routine was required.
In the early nineties, the concept of the fast-track path-
way in cardiac surgery was introduced. Although more
directed at early extubation, this new trend involved a
multifactorial approach aimed at improving care in car-
diosurgical patients.2 Intraoperative high-dose narcotic
anaesthesia switched to lighter volatile based anaesthe-
sia, or intravenous short-acting anaesthetic agents, allow-
ing early respiratory weaning. The objective was to end
general anaesthesia soon after surgery and restore the
patient’s respiratory autonomy. Rapid extubation
improved the interaction between patient and caregiver,
allowing early mobilisation and intensive postoperative
respiratory physiotherapy. Therefore, improved pain
control after cardiac surgery emerged as a challenge to
improve patient comfort and reduce complications.3
Unfortunately, pain after cardiac surgery is a multifactor-
ial condition involving median sternotomy, chest open-
ing, internal mammary dissection, mediastinal and
pleural drains, and saphenous vein harvest. Continuous
intravenous infusion of opioids seemed to be a valid
therapy, but it induces several adverse effects, including
respiratory depression, decreased gastrointestinal moti-
lity, nausea and vomiting. These undesirable compli-
cations were deleterious to the patient, potentially
leading to an unfavourable outcome. Multimodal analge-
sia, based on nonopioid systemic analgesics or a combi-
nation of different pain control techniques, appeared a
valid alternative.
Several analgesic approaches have been investigated in
patients undergoing cardiac surgery. In this setting,
intrathecal or epidural analgesia, performed before the
induction of general anaesthesia, was attempted. Neuro-
axial use of local anaesthetics, opioids or both, allowed
the control of intraoperative and postoperative pain.4
This strategy, associated with short-acting anaesthesia
agents, made extubation possible while still in the oper-
ation theatre.5 Although good analgesic results were
demonstrated, the clinical application of neuro-axial
analgesia, combined with general anaesthesia, remains
problematic in cardiac surgery. The most frequent
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adverse effect is sympathetic nerve blockade that induces
vasoplegia and hypotension. Pruritus, nausea and urinary
retention are also commonly observed. But the most
threatening complication is epidural bleeding in patients
who require anticoagulation during cardiopulmonary
bypass that may occur in up to 1 : 3500 procedures.
Finally, central neuraxial techniques are not routinely
performed on patients undergoing cardiac surgery
because of procedural risks, dual antiplatelet therapy
and the lack of a consensus about the real impact on
morbidity and mortality.6 Paravertebral local anaesthetic
infiltration has not been widely adopted by cardiac anaes-
thetists or surgeons despite promising results, as median
sternotomy needs a bilateral approach.7
Continuous wound infusion of local anaesthetics for pain
control has been shown to be efficacious for a variety of
surgical procedures.8 In this issue of the Journal, Eljezi
et al.9 report the results of a randomised, observer-blinded
controlled trial in 120 patients with high respiratory
complication risks after cardiac surgery. The authors
compared a postoperative systemic intravenous opioid
based protocol with subcutaneous analgesia. The primary
end-point was the time needed for eligibility for ICU
discharge, according to established clinical criteria
included in a checklist. Three independent observers
blindly assessed the fulfilment of all discharge criteria.
The final ICU length of stay analysis showed no signifi-
cant statistical difference (intent-to-treat P¼ 0.680, per-
protocol P¼ 0.873). This result is not so surprising, as
postoperative cardiac surgery management is based on a
comprehensive multifactorial recovery programme. In
this process, pain control represents only one component,
among others, that improves patient care. The authors
reported enhanced patient comfort in the intervention
group (P< 0.0001), but subcutaneous analgesia needs
future technical improvements, as the results of the
present study do not show any significant difference in
mean morphine consumption between the two groups
(45 vs. 43 mg). Among the encouraging secondary out-
comes reported, the lower rate of pulmonary compli-
cations (23% control vs. 4% intervention group) is
noteworthy in this selected subgroup of patients with a
high risk of postoperative respiratory complications. The
underlying mechanism is likely to be the reduction of
dynamic pain allowing early mobilisation, free respiratory
movements, facilitation of efficient coughing and less
atelectasis.10
In summary, analgesia alone does not allow shortening of
ICU stay, but does represent a crucial factor in improving
the postoperative course. Given the risk of local anaes-
thetic toxicity, the authors should be congratulated on
investigating this potentially serious adverse effect. They
found that the minimal plasma threshold for neurotoxi-
city was surpassed in 22% of treated patients. Although
there were no clinical consequences, this outcome should
not be underestimated and the underlying tissue absorp-
tion mechanism needs to be understood properly before
promoting more widespread use of this technique. This
study has limitations, but it highlights how a subcu-
taneous approach, combined with systemic intravenous
analgesia, reduces dynamic pain and respiratory compli-
cations after cardiac surgery. This minimally invasive
analgesia modality represents a step towards optimal
postoperative pain control with low procedural risks.
Acknowledgements relating to this article
Assistance with the Commentary: none.
Financial support and sponsorship: none.
Conflicts of interest: none.
Comment from the Editor: this Invited Commentary was checked
and accepted by the editors but was not sent for external peer
review.
References
1 Lunn JK, Stanley TH, Eisele J, et al. High dose fentanyl anesthesia for
coronary artery surgery: plasma fentanyl concentrations and influence of
nitrous oxide on cardiovascular responses. Anesth Analg 1979; 58:390–
395.
2 Cheng DCH, Karski J, Peniston C, et al. Early tracheal extubation after
coronary artery bypass graft surgery reduces costs and improves resource
use: a prospective, randomized, controlled trial. Anesthesiology 1996;
85:1300–1310.
3 Gust R, Pecher S, Gust A, et al. Effect of patient-controlled analgesia on
pulmonary complications after coronary artery bypass grafting. Crit Care
Med 1999; 27:2218–2223.
4 Chaney MA. Intrathecal and epidural anesthesia and analgesia for cardiac
surgery. Anesth Analg 2006; 102:45–64.
5 Hemmerling TM, Leˆ N, Olivier JF, et al. Immediate extubation after aortic
valve surgery using high thoracic epidural analgesia or opioid-based
analgesia. J Cardiothorac Vasc Anesth 2005; 19:176–181.
6 Svircevic V, Passier MM, Nierich AP, et al. Epidural analgesia for cardiac
surgery. Cochrane Database Syst Rev 2013;CD006715.
7 Olivier JF, Bracco D, Nguyen P, et al. A novel approach for pain
management in cardiac surgery via median sternotomy: bilateral single-shot
paravertebral blocks. Heart Surg Forum 2007; 10:357–362.
8 Liu S, Richman JM, Thirlby RC, et al. Efficacy of continuous wound
catheters delivering local anesthetic for postoperative analgesia: a
quantitative and qualitative systematic review of randomized controlled
trials. J Am Coll Surg 2006; 203:914–932.
9 Eljezi V, Imhoff E, Bourdeaux D, et al.Bilateral sternal infusion of ropivacaine
and length of stay in ICU after cardiac surgery with increased respiratory
risk: a randomised controlled trial. Eur J Anaesthesiol 2017; 34:56–65.
10 Westerdahl E, Lindmark B, Eriksson T, et al. Deep-breathing exercises
reduce atelectasis and improve pulmonary function after coronary artery
bypass surgery. Chest 2005; 128:3482–4348.
Minimally invasive analgesia after cardiac surgery 55
Eur J Anaesthesiol 2017; 34:54–55
